SCHEMBL371339

SCHEMBL371339

CC(c1ccc2ncccc2c1)S(=O)(=O)Nc1nn(-c2cnn(C)c2)ccc1=O

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MET P08581 17/20 0.50
PDE3A Q14432 6/20 0.41
PDE4C Q08493 2/20 0.41
PDE4D Q08499 2/20 0.41
PDE3B Q13370 2/20 0.41
PDE10A Q9Y233 2/20 0.41
PDE2A O00408 1/20 0.41
CHRM2 P08172 1/20 0.41
PDE4A P27815 1/20 0.41
PDE1A P54750 1/20 0.41
PDE4B Q07343 1/20 0.41
PDE1C Q14123 1/20 0.41
PDE11A Q9HCR9 1/20 0.41
EGFR P00533 1/20 0.36
ERBB2 P04626 1/20 0.36
ERBB4 Q15303 1/20 0.36
WNT1 P04628 1/20 0.34
DYRK1A Q13627 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL359556 0.86 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL369157 0.81 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL14917080 0.81 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL14917105 0.81 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL2269727 0.80 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL359518 0.79 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL14915679 0.79 MET (0.52) METPDE3APDE4CPDE4DPDE3B
SCHEMBL2221691 0.79 MET (0.51) METPDE3APDE4CPDE4DPDE3B
SCHEMBL358990 0.78 MET (0.45) METPDE10AEGFRERBB2ERBB4
SCHEMBL14916384 0.75 MET (0.47) METPDE3APDE4CPDE4DPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593107-A1 TYROSINE KINASE INHIBITORS Merck Sharp & Dohme Corp. (US) 2013-05-22 EP disclosed
WO-2012009194-A1 TYROSINE KINASE INHIBITORS MERCK SHARP & DOHME CORP. (US) 2012-01-19 WO disclosed